DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors
The Journal of Experimental Medicine (2002) - Comments
pubmed: 12235210  issn: 0022-1007  doi: 10.1084/jem.20020179  issn: 1540-9538 

Alex I. Zaika, Neda Slade, Susan H. Erster, Christine Sansome, Troy W. Joseph, Michael Pearl, Eva Chalas, Ute M. Moll